NASDAQ:RMTI - Rockwell Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rockwell Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.69 +0.12 (+4.67 %) (As of 01/28/2020 06:00 AM ET) Add Compare Today's Range$2.49Now: $2.69▼$2.8250-Day Range$2.20MA: $2.41▼$2.8352-Week Range$1.81Now: $2.69▼$6.88Volume360,819 shsAverage Volume396,242 shsMarket Capitalization$172.04 millionP/E RatioN/ADividend YieldN/ABeta1.49 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Rockwell Medical, Inc operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:RMTI Previous Symbol CUSIP77437410 CIK1041024 Webhttp://www.rockwellmed.com/ Phone248-960-9009Debt Debt-to-Equity Ratio0.07 Current Ratio3.27 Quick Ratio2.98Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$63.39 million Price / Sales2.71 Cash FlowN/A Price / Cash FlowN/A Book Value$0.48 per share Price / Book5.60Profitability EPS (Most Recent Fiscal Year)($0.47) Net Income$-32,130,000.00 Net Margins-57.77% Return on Equity-139.38% Return on Assets-68.00%Miscellaneous Employees269 Outstanding Shares63,956,000Market Cap$172.04 million Next Earnings Date3/12/2020 (Estimated) OptionableOptionable Receive RMTI News and Ratings via Email Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:RMTI Rates by TradingView Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions What is Rockwell Medical's stock symbol? Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI." How were Rockwell Medical's earnings last quarter? Rockwell Medical Inc (NASDAQ:RMTI) issued its quarterly earnings results on Monday, November, 11th. The company reported ($0.12) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.14) by $0.02. The firm earned $15.41 million during the quarter, compared to analysts' expectations of $15.40 million. Rockwell Medical had a negative return on equity of 139.38% and a negative net margin of 57.77%. View Rockwell Medical's Earnings History. When is Rockwell Medical's next earnings date? Rockwell Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Rockwell Medical. What price target have analysts set for RMTI? 4 brokerages have issued twelve-month price targets for Rockwell Medical's shares. Their forecasts range from $6.00 to $11.00. On average, they anticipate Rockwell Medical's share price to reach $9.33 in the next year. This suggests a possible upside of 247.0% from the stock's current price. View Analyst Price Targets for Rockwell Medical. What is the consensus analysts' recommendation for Rockwell Medical? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical. Has Rockwell Medical been receiving favorable news coverage? Media coverage about RMTI stock has trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rockwell Medical earned a news impact score of -1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Rockwell Medical. Who are some of Rockwell Medical's key competitors? Some companies that are related to Rockwell Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and Steris (STE). What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include JinkoSolar (JKS), Immunomedics (IMMU), Seattle Genetics (SGEN), Iovance Biotherapeutics (IOVA), Eyepoint Pharmaceuticals (EYPT), Gilead Sciences (GILD), Heron Therapeutics (HRTX), ImmunoGen (IMGN), Portola Pharmaceuticals (PTLA) and AcelRx Pharmaceuticals (ACRX). Who are Rockwell Medical's key executives? Rockwell Medical's management team includes the folowing people: Mr. Stuart Paul, Pres, CEO & Director (Age 59)Mr. Angus W. Smith, Chief Financial Officer (Age 36)Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)Mr. Michael DeYoung, VP of OperationsMr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51) Who are Rockwell Medical's major shareholders? Rockwell Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.12%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond and Stuart M Paul. View Institutional Ownership Trends for Rockwell Medical. Which major investors are buying Rockwell Medical stock? RMTI stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond and Stuart M Paul. View Insider Buying and Selling for Rockwell Medical. How do I buy shares of Rockwell Medical? Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Rockwell Medical's stock price today? One share of RMTI stock can currently be purchased for approximately $2.69. How big of a company is Rockwell Medical? Rockwell Medical has a market capitalization of $172.04 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.View Additional Information About Rockwell Medical. What is Rockwell Medical's official website? The official website for Rockwell Medical is http://www.rockwellmed.com/. How can I contact Rockwell Medical? Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected] MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 267 (Vote Outperform)Underperform Votes: 292 (Vote Underperform)Total Votes: 559MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/28/2020 by MarketBeat.com StaffFeatured Article: What is the Euro STOXX 50 Index?
